JM
James G Murphy
Director

James G Murphy insider trades: Biomimetic Therapeutics (BMTI) stock purchases

Director, Biomimetic Therapeutics Last trade Jun 25, 2009 23 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
12
Open-market trades
since 2007
2
Companies
last trade 2009

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where James reports to the SEC

Open-market buys and sales

12 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jun 25, 2009BMTI↑ Buy$4K
Mar 28, 2008BMTI↑ Buy$42K
Mar 21, 2007IMMC↑ Buy$3K
Mar 14, 2007IMMC↑ Buy$3K
Mar 7, 2007IMMC↑ Buy$3K
Feb 28, 2007IMMC↑ Buy$3K
Feb 14, 2007IMMC↑ Buy$3K
Feb 7, 2007IMMC↑ Buy$3K
Jan 31, 2007IMMC↑ Buy$3K
Jan 24, 2007IMMC↑ Buy$3K
Jan 17, 2007IMMC↑ Buy$3K
Jan 10, 2007IMMC↑ Buy$3K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About James G Murphy's insider trades

James G Murphy is a director at Biomimetic Therapeutics (BMTI). Since Jan 10, 2007, James has reported 12 open-market purchases worth $78K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (9 filings), option exercises (2 filings), shares returned to the company (1 filing), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BMTI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.